Comparison of Perioperative Opioid Consumption Following Pectoral Nerve Block for Breast Cancer Surgery

• Status: Completed
• Trial end date: 2017-09-15
• Target enrollment: 0
• Participant gender: Female

Summary

In this study, the investigators will compare the intraoperative opioid consumption for patients undergoing breast cancer surgery. The patients will be divided in two groups, the first one will receive a pectoral nerve block right after induction of anesthesia and the second one, the control group, will not receive the pectoral block. Our hypothesis is that the pectoral nerve block reduces the opioid consumption during the surgery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Maisonneuve-Rosemont Hospital
• Treatments: Analgesics, Opioid; Epinephrine; Epinephryl borate; Lidocaine; Racepinephrine

Criteria

Inclusion Criteria:

• ASA 1 to 3 inclusively

• breast cancer surgery with or without axillary dissection

Exclusion Criteria:

• any contraindication to the pectoral nerve block (coagulopathy, infection, pre- existing neuropathy, local anesthetic allergy and refusal of local anesthesia)

• refusal to participate in the study

• patient with dementia

• preoperative breast pain

• preoperative opioid consumption

• breast reconstructive surgery

• bilateral surgery

• pregnant patient